These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 39393)

  • 1. [Metabolic studies during urinary diversion by way of the small intestine].
    Schneider HJ; Bockhorn V
    Z Urol Nephrol; 1979 May; 72(5):365-74. PubMed ID: 39393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B; Rahman MA
    Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of dietary factors on the risk of urinary stone formation.
    Hesse A; Siener R; Heynck H; Jahnen A
    Scanning Microsc; 1993 Sep; 7(3):1119-27; discussion 1127-8. PubMed ID: 8146611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study on the cause of urolithiasis of the upper urinary tract--clinical study of risk factors in the formation of stones in the upper urinary tract].
    Nonomura M; Kawamura J; Ueda M; Okada Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1986 Mar; 32(3):311-25. PubMed ID: 3728237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of calcium, oxalate, and citrate interaction in idiopathic calcium urolithiasis in children.
    Milosević D; Batinić D; Konjevoda P; Blau N; Stambuk N; Nizić L; Vrljicak K; Batinić D
    J Chem Inf Comput Sci; 2003; 43(6):1844-7. PubMed ID: 14632431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine composition following jejunoileal bypass.
    Nordenvall B; Backman L; Larsson L; Tiselius HG
    Eur Urol; 1983; 9(1):35-9. PubMed ID: 6822241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA; Hennequin C; Lacour B; Daudon M
    Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk indicators of urinary calculus formation: value of oxalate and citrate excretion in comparison with the oxalate tolerance value].
    Hannak D; Burczyk U; Bartelt U; Kattermann R
    Urologe A; 1989 Jan; 28(1):20-4. PubMed ID: 2922896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evolution of strategy to measure urinary supersaturation].
    Morita N; Moriyama M; Miyazawa K; Tanaka T; Suzuki K
    Hinyokika Kiyo; 2011 Jan; 57(1):35-8. PubMed ID: 21304259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A thermodynamic equilibrium model for calcium salt urolithiasis: clinical application.
    Ashby R; Györy AZ
    Exp Nephrol; 1997; 5(3):246-52. PubMed ID: 9208285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Computer calculations on the effect of urine components on saturation relations of calcium oxalate in the urine].
    Matouschek E; Huber RD
    Urologe A; 1984 Mar; 23(2):70-6. PubMed ID: 6547011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Urinary stone in a Bricker's ileal conduit].
    Parra Muntaner L; López Pacios JC; Vega Vega A; Rodríguez Faba O; Sánchez Merino JM; Madrid García JF; Piñeiro Fernández Mdel C; Yañez Cisneros SC; García Alonso J
    Arch Esp Urol; 2004 Oct; 57(8):851-3. PubMed ID: 15560277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M; Ikegami M; Kiwamoto H; Umekawa T; Ishikawa Y; Kohri K; Kurita T
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Examination of the risk factors for infectious urolithiasis formation in patients receiving urinary diversion or urinary reconstruction using intestine--comparison of reservoir and ileal conduit].
    Takeda M; Katayama Y; Takahashi H; Go H; Tsutsui T; Nishiyama T; Sato S; Nakamura S
    Hinyokika Kiyo; 1993 May; 39(5):419-24. PubMed ID: 8322623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
    Sakhaee K; Poindexter JR; Griffith CS; Pak CY
    J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Circadian rhythms of lithogenic and inhibitory substances in the urine].
    Ebisuno S; Morimoto S; Yasukawa S; Yoshida T; Fukatani T; Minakata S; Uehara M; Ohkawa T
    Hinyokika Kiyo; 1986 May; 32(5):667-71. PubMed ID: 3751794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.